-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
-
Medication Adherence and Persistence
-
Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
-
Measurement Comparability Between Modes of Administration of PROMs
- Performance Outcome (PerfO) Assessments
- Quantitative Benefit-Risk Assessment
- Systematic Reviews with Cost and Cost-Effectiveness Outcomes
- Using Patient Preferences to Inform Decision Making
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 1
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 2
- Replicate, Regulate, and Redefine: RWE Use Cases in the Next Decade - Session 3
-
Professional Development Resources
The Executive Committee is the policy- and decision-making body of the ISPOR Arabic Network and is responsible for the development of the ISPOR Arabic Network. It facilitates ISPOR activities in the region and oversees initiatives led by the Network. It is composed of the current President of each ISPOR Regional Chapter in Western Asia and North Africa (where Arabic is the official language) and the chair of the working committees.
Please contact the ISPOR Global Networks-EMEA Team here with any questions.
Chair
Mahmoud Elmahdawy, PharmD, MD
Chair Elect
Rita Karam, PharmD, PhD, DrPH
ISPOR Arabic Network Executive Committee Members
Algeria Chapter
Mokhtaria Bezaoucha, PharmD
Head of Regulation, Algerian National Agency of Pharmaceutical Products
Algiers, Algeria
Lebanon Chapter
Mirna Metni, PharmD
Member of the medical jury of the National Social Security Fund
Social Security-Medical Control Sector
Beirut, Lebanon
Egypt Chapter
Mahmoud Elmahdawy, PharmD
Lecturer of Clinical and Hospital Pharmacy, Misr International University
Cairo, Egypt
Qatar Chapter
Daoud Al-Badriyeh, PhD
Assistant Professor of Pharmacoeconomics
College of Pharmacy, Qatar University
Doha, Qatar
Jordan Chapter
Ibrahim Alabbadi, PhD, MBA, BPharm
Associate Professor of Pharmacoeconomics & Pharmaceutical Marketing
Dean, Faculty of Pharmacy, Yarmouk University
Irbid, Jordan
Saudi Arabia Chapter
Abdulaziz H. Al-Saggabi, MSc, PharmD
Director, Drug Policy & Economics Center,
Ministry of National Guard Health Affairs
Riyadh, Saudi Arabia
Kuwait Chapter
Maryam Alowayesh, PhD
Assistant Professor, School of Pharmacy
Kuwait University
Jabriyah, Kuwait
United Arab Emirates Chapter
Ola Ghaleb Alahdab, PhD
Pharmaceutical Advisor, CPD-Pharma Program Manager
Registration and Drug Control Department, Ministry of Health
Abu Dhabi, UAE